Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
LEO Pharma sells portfolio of four products to Cheplapharm
BALLERUP, Denmark, August 31 – Today, LEO Pharma A/S announced the sale of a portfolio of four non-core products to Cheplapharm for EUR 300 million.
Does the COVID-19 cytokine storm exist?
Inflammatory proteins, also known as cytokines, play a crucial role in the immune response.
Protein discovery could improve type 2 diabetes treatment
A world first discovery of how a protein works in the liver could lead to a more effective type 2 diabetes drug.
China offers coronavirus vaccine candidates to aviation industry workers: notice
BEIJING (Reuters) - China has offered experimental coronavirus vaccines to aviation industry workers, according to a regulatory notice seen by Reuters, in a push to inoculate high-risk groups ...
California may be the first state to develop its own generic drugs
SACRAMENTO — California is poised to become the first state to develop its own line of generic drugs, targeting soaring drug prices and stepping into a fiercely competitive drug market dominated by ...
Sanofi, GSK to start potential COVID-19 vaccine trial
Paris-based pharmaceutical company Sanofi and pharma giant GSK announced Thursday they are starting clinical trials of their COVID-19 vaccine.
WHO updates clinical care guidance with corticosteroid recommendations
On 2 September, WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
Oxford Biomedica Signs Supply Agreement with AstraZeneca to Expand Manufacturing Support of COVID-19 Vaccine Candidate, AZD1222
Oxford, UK – 1 September, 2020.
Jubilant Life Sciences seeks nod to roll out Remdesivir tablet
NEW DELHI.
Honeybee venom compound shown to kill aggressive breast cancer cells: Aussie research
SYDNEY, Sept.
Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program
FOSTER CITY, Calif.
AZ' Imfinzi bags new approval for lung cancer
AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union for the first-line treatment of adults with extensive-stage small cell lung cancer (ES-SCLC) in combination...
287
288
289
290
291
292
293
294
295
